March 19, 2012
UC San Diego Moores Cancer Center has one of the first oncology practices in the nation to be recognized by the Quality Oncology Practice Initiative (QOPI®) Certification Program, an affiliate of the American Society of Clinical Oncology (ASCO). The QOPI® Certification Program is a new initiative to certify oncology practices…
November 22, 2022
The UC San Diego Sanford Stem Cell Institute leads its first space launch, sending stem cells into space aboard the International Space Station. The NASA-partnered study will take advantage of the microgravity environment of space to study accelerated aging in stem cells.
February 7, 2023
A novel drug combination for leukemia, pioneered at UC San Diego Health, provides patients with a better treatment option that results in less side effects and can put patients in remission.
April 13, 2012
Scott M. Lippman, MD, chair of Thoracic/Head and Neck Medical Oncology at The University of Texas (UT) MD Anderson Cancer Center, has accepted the position of director of Moores Cancer Center at the University of California, San Diego, beginning May 1, 2012.
January 12, 2017
The next presentation in UC San Diego’s “Inside Innovation” series features Dr. Catriona Jamieson speaking on “Detection and Therapeutic Targeting of Cancer Stem Cell Evolution.” The free and public presentation will be held 4-6 p.m. on Tuesday, Jan. 17, in Roth Auditorium at the Sanford Consortium for Regenerative Medicine, 2880…
December 10, 2020
Researchers recently created detailed simulations on the Comet system at the San Diego Supercomputer Center showing how these stiff red blood cells flow through blood vessels, deforming and colliding along the way.
February 15, 2022
UC San Diego Health researchers surveyed and compared early- and late-stage breast and colorectal cancer diagnoses in patients in pre-pandemic 2019 and in 2020, the first full year of the COVID-19 pandemic, discovering fewer of the former and more of the latter as patients delayed care.
June 6, 2018
Patients at UC San Diego Health can now read the medical notes signed by their primary care physician. This move toward transparency is part of an international trend to make patients feel more in control of their health care.
May 5, 2014
With accelerating development of personalized cancer treatments matched to a patient’s DNA sequencing, proponents say frontline physicians increasingly need help to maneuver through the complex genomic landscape to find the most effective, individualized therapy.
July 27, 2012
Using a new assay method to study tumor cells, researchers at the University of California, San Diego School of Medicine and UC San Diego Moores Cancer Center have found evidence of clonal evolution in chronic lymphocytic leukemia (CLL). The assay method distinguishes features of leukemia cells that indicate whether the…
